Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 380
Filter
1.
Eur Heart J Acute Cardiovasc Care ; 13(3): 304-312, 2024 Mar 11.
Article in English | MEDLINE | ID: mdl-38135288

ABSTRACT

Acute right ventricular failure secondary to acutely increased right ventricular afterload (acute cor pulmonale) is a life-threatening condition that may arise in different clinical settings. Patients at risk of developing or with manifest acute cor pulmonale usually present with an acute pulmonary disease (e.g. pulmonary embolism, pneumonia, and acute respiratory distress syndrome) and are managed initially in emergency departments and later in intensive care units. According to the clinical setting, other specialties are involved (cardiology, pneumology, internal medicine). As such, coordinated delivery of care is particularly challenging but, as shown during the COVID-19 pandemic, has a major impact on prognosis. A common framework for the management of acute cor pulmonale with inclusion of the perspectives of all involved disciplines is urgently needed.


Subject(s)
Cardiology , Heart Failure , Pulmonary Heart Disease , Humans , Pulmonary Heart Disease/diagnosis , Pulmonary Heart Disease/etiology , Pulmonary Heart Disease/therapy , Pandemics , Heart Failure/diagnosis , Heart Failure/etiology , Heart Failure/therapy , Heart Ventricles
2.
Contrast Media Mol Imaging ; 2022: 3618592, 2022.
Article in English | MEDLINE | ID: mdl-36277594

ABSTRACT

As a heart disease caused by pulmonary arterial hypertension, pulmonary heart disease has a high incidence and poor clinical prognosis in the elderly. Including mechanical ventilation in the current clinical treatment of cor pulmonale, with the development of medical technology, traditional invasive mechanical ventilation has been pointed out to have certain clinical limitations, so new invasive and noninvasive sequential ventilation treatments are gradually being used. Applied in clinical practice, this article selected 96 patients with severe cor pulmonale in our hospital from January 2020 to May 2021 as the research object and conducted a randomized prospective study. The experimental results show that the two general methods can improve the blood gas index and pulmonary function index of patients with heart disease and pulmonary dysfunction, but the improvement of the above indexes by the sequence of action of gas therapy is better than that of conventional invasive mechanical ventilation.


Subject(s)
Hypertension, Pulmonary , Pulmonary Heart Disease , Humans , Aged , Pulmonary Heart Disease/therapy , Pulmonary Heart Disease/etiology , Prospective Studies , Hypertension, Pulmonary/therapy , Hypertension, Pulmonary/complications , Chronic Disease , Treatment Outcome
3.
J Healthc Eng ; 2022: 8495996, 2022.
Article in English | MEDLINE | ID: mdl-35378941

ABSTRACT

Chronic obstructive pulmonary disease is a common respiratory disease. This paper observes the effects of cardiopulmonary rehabilitation promotion mode intervention combined with oxygen therapy on cardiopulmonary function and blood gas analysis indexes in patients with chronic obstructive pulmonary disease (COPD) complicated with cor pulmonale. A total of 136 COPD patients with cor pulmonale admitted to our hospital from July 2018 to October 2020 were selected as the research objects and divided into two groups by a simple random method. 136 patients are given oxygen therapy while the traditional group and cardiopulmonary rehabilitation group are given traditional mode and cardiopulmonary rehabilitation promotion mode intervention. Cardiopulmonary rehabilitation promotion mode intervention combined with oxygen therapy can improve the cardiopulmonary function of COPD patients with cor pulmonale, regulate the expression of related serum factors, improve self-care ability, and reduce the number of hospitalizations.


Subject(s)
Pulmonary Disease, Chronic Obstructive , Pulmonary Heart Disease , Blood Gas Analysis , Humans , Oxygen , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/therapy , Pulmonary Heart Disease/complications , Pulmonary Heart Disease/therapy
4.
J Int Med Res ; 48(11): 300060520965839, 2020 Nov.
Article in English | MEDLINE | ID: mdl-33208014

ABSTRACT

OBJECTIVES: This study aimed to evaluate the effects of external diaphragmatic pacing (EDP) on patients with chronic cor pulmonale (CCP). METHODS: Fifty patients with CCP were enrolled in Kashgar Prefecture Second People's Hospital in Xinjiang Uygur Autonomous Region of China from 2016 to 2017. The patients were randomized into a group that received anti-CCP therapy (negative control group) or a group that received additional EDP treatment (EDP group). We recorded and compared maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC, and the 6-minute walking test between the two groups on the first and tenth days of treatment. RESULTS: Ten days after treatment began, MIP, FVC, and the 6-minute walking test were significantly improved in both groups. Importantly, MIP and FVC were significantly higher in the EDP group compared with the control group on the tenth day. CONCLUSION: In addition to treatment for CCP, these patients can obtain extra benefit by using EDP treatment.


Subject(s)
Pulmonary Heart Disease , China , Forced Expiratory Volume , Humans , Pulmonary Heart Disease/therapy , Respiratory Muscles , Vital Capacity
6.
Rev Mal Respir ; 37(3): 257-266, 2020 Mar.
Article in French | MEDLINE | ID: mdl-32088063

ABSTRACT

Cor pulmonale is a disease of the heart characterised by dilatation of the right ventricle and paradoxical movement of the interventricular septum. The diagnosis depends on echocardiography even if pulmonary artery catheterisation suggests it. It is secondary to pulmonary disease or a disorder of the pulmonary circulation. These two mechanisms, which are often connected, involve pulmonary hypertension as the origin of a systolic and diastolic overload of the right ventricle, which then leads to the alterations of its structure and performance. Acute cor pulmonale is usually secondary to an acute respiratory distress syndrome or to a pulmonary embolism but it can also be seen in primary lactic acidosis, a vaso-occlusive crisis in a patient with sickle cell anaemia, severe acute asthma, and entry of air or injected crushed tablets into the circulation. Chronic cor pulmonale is the terminal stage of pulmonary hypertension. Clinically these patients are dyspnoeic with signs of chronic right heart failure. They should have an echocardiogram confirming the cardiac involvement. Certain precipitating factors, such as infection of any origin, have been reported, leading to acute on chronic cor pulmonale that has a particularly high mortality.


Subject(s)
Pulmonary Heart Disease/etiology , Ventricular Dysfunction, Right/complications , Chronic Disease , Diagnosis, Differential , Echocardiography , Heart Failure/diagnosis , Heart Failure/etiology , Heart Failure/prevention & control , Humans , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/therapy , Pulmonary Embolism/diagnosis , Pulmonary Embolism/etiology , Pulmonary Embolism/therapy , Pulmonary Heart Disease/diagnosis , Pulmonary Heart Disease/therapy , Respiratory Distress Syndrome/diagnosis , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/therapy , Ventricular Dysfunction, Right/diagnosis , Ventricular Dysfunction, Right/therapy
7.
Ann Card Anaesth ; 22(2): 229-232, 2019.
Article in English | MEDLINE | ID: mdl-30971611

ABSTRACT

Perioperative complications of prolonged surgery and prone positioning are well known. Changing the position from prone to supine in an anesthetized patient can result in aspiration and airway obstruction. The drop-in oxygen saturation and hemodynamic changes are warning signs and can cause acute cardiac decompensation leading to diagnostic dilemma. We present a case where the patient had these changes after changing the position after spine surgery in prone position. A quick response from the treating anesthesiologist and active involvement of cardiologist helped in reaching the diagnosis and successful management of aspiration pneumonitis in this patient. We conclude that a quick response in investigations and multimodality approach helps in the management of such perioperative complications.


Subject(s)
Cardiopulmonary Resuscitation/methods , Intraoperative Complications/etiology , Intraoperative Complications/therapy , Patient Positioning/adverse effects , Pulmonary Heart Disease/etiology , Pulmonary Heart Disease/therapy , Spine/surgery , Acute Disease , Adult , Female , Humans , Posture
9.
J Tradit Chin Med ; 36(3): 283-90, 2016 Jun.
Article in Chinese | MEDLINE | ID: mdl-27468541

ABSTRACT

OBJECTIVE: To evaluate the efficacy of integrated Traditional Chinese Medicine-Western Medicine (TCM-WM) in the treatment of acute onset pulmonary heart disease (PHD). METHODS: A total of 240 patients met the inclusion criteria and were enrolled. These inpatients were divided into group A (treatment group) and B (control group) in order of admission according to the principles of randomization and control. The research was performed simultaneously in three hospitals. Two groups were given basic treatment that included: controlled oxygen therapy, active and effective anti-infection, maintaining airway patency, correcting O2 deficiency and CO2 retention, correcting acid-base imbalance and electrolyte disturbance, reducing pulmonary hypertension and treating right heart failure, nutritional support and treatment of.complications. Group A was given basic treatment and integrated Traditional Chinese Medicine (TCM) differentiating therapy; group B was given basic therapy and a placebo that was similar in appearance and taste to TCM medicinal broth of pharmaceutical preparations, provided by Yibin Pharmaceutical Company (Yibin, China, Wuliangye Group). RESULTS: The mortality in the treatment group decreased by 4.98% compared with the control group. The treatment group reported improved ventilation, corrected hypoxemia, improved nutritional status and promoted digestive functions. It also significantly improved the patient's self-life skills, improved the patient's quality of life and could shorten the length of hospital stay. CONCLUSION: Comprehensive integrated TCM-WM treatment showed good clinical efficacy toward the acute onset period of PHD patients.


Subject(s)
Drugs, Chinese Herbal/administration & dosage , Hyperbaric Oxygenation , Pulmonary Heart Disease/therapy , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Pulmonary Heart Disease/drug therapy , Treatment Outcome
10.
Curr Opin Crit Care ; 22(1): 38-44, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26627538

ABSTRACT

PURPOSE OF REVIEW: Circulatory failure is a frequent complication during acute respiratory distress syndrome (ARDS) and is associated with a poor outcome. This review aims at clarifying the mechanisms of circulatory failure during ARDS. RECENT FINDINGS: For the past decades, the right ventricle (RV) has gained a crucial interest since many authors confirmed the high incidence of acute cor pulmonale during ARDS and showed a potential role of the acute cor pulmonale in the poor outcome of ARDS patients. The most important recent progress demonstrated in ARDS ventilatory strategy is represented by the prone position, which has a huge beneficial effect on RV afterload. This review will focus on the mechanisms responsible for the RV dysfunction/failure during ARDS and on the strategy, which allows improving the right ventricular function. SUMMARY: The RV has a pivotal role in the circulatory failure of ARDS patients. The ventilatory strategy during ARDS has to pay a peculiar attention to the RV to rigorously control its afterload.


Subject(s)
Hemodynamics/physiology , Pulmonary Heart Disease/physiopathology , Respiration, Artificial/adverse effects , Respiratory Distress Syndrome/therapy , Ventricular Dysfunction, Right/physiopathology , Critical Care/methods , Female , Humans , Male , Prognosis , Pulmonary Heart Disease/etiology , Pulmonary Heart Disease/mortality , Pulmonary Heart Disease/therapy , Respiration, Artificial/methods , Respiratory Distress Syndrome/complications , Respiratory Distress Syndrome/mortality , Respiratory Distress Syndrome/physiopathology , Respiratory Function Tests , Respiratory Insufficiency/etiology , Respiratory Insufficiency/mortality , Respiratory Insufficiency/physiopathology , Respiratory Mechanics , Risk Assessment , Severity of Illness Index , Survival Rate , Treatment Outcome , Ventricular Dysfunction, Right/etiology , Ventricular Dysfunction, Right/mortality
11.
J Anesth ; 30(1): 161-5, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26446805

ABSTRACT

Electrical impedance tomography (EIT) is a noninvasive technique used to assess regional gas distribution in the lung. We experienced a patient with acute cor pulmonale during high positive-pressure ventilation for the treatment of severe acute respiratory distress syndrome. Prone positioning was beneficial for unloading the right ventricle for treatment of acute cor pulmonale. EIT played a role in detecting lung derecruitment at the patient's bedside. Impedance distribution in ventral, mid-ventral, mid-dorsal, and dorsal layers before and 20 min after the start of prone positioning was 9, 48, 44, and 0 %, and 10, 25, 48, and 16 %, respectively. Lung recruitment monitored by EIT paralleled the improvement of PaO2/FIO2 from 123 to 239 mmHg. Timing of termination of prone positioning and ventilator settings such as lowering positive end-expiration pressure was determined to maintain dorsal recruitment as seen by EIT. The patient was weaned from mechanical ventilation on day 32 and discharged on day 200. EIT assessed the effects of prone positioning with real-time dynamic imaging and guided less injurious mechanical ventilation in a patient with acute cor pulmonale with dorsal lung derecruitment.


Subject(s)
Positive-Pressure Respiration/methods , Pulmonary Heart Disease/therapy , Respiratory Distress Syndrome/therapy , Tomography/methods , Aged , Electric Impedance , Female , Humans , Prone Position , Respiration, Artificial/methods
12.
Am J Cardiol ; 115(5): 697-703, 2015 Mar 01.
Article in English | MEDLINE | ID: mdl-25727086

ABSTRACT

Described are certain clinical and morphologic features of one patient with acute, another with subacute, and one with chronic cor pulmonale. All 3 had evidence of severe pulmonary hypertension. The patient with acute cor pulmonale 4 days after coronary bypass for unstable angina pectoris suddenly developed severe breathlessness with cyanosis and had fatal cardiac arrest and necropsy disclosed massive pulmonary embolism. The patient with subacute cor pulmonale had severe right-sided heart failure for 5 weeks and necropsy disclosed microscopic-sized neoplastic pulmonary emboli from a gastric carcinoma without parenchymal pulmonary metastases. The patient with chronic cor pulmonale had evidence of right-sided heart failure for years, the result of primary or idiopathic pulmonary hypertension almost certainly present from birth because the pattern of elastic fibers in the pulmonary trunk was that seen in newborns where the pressure in the pulmonary trunk and ascending aorta are similar. The patient with chronic cor pulmonale had plexiform pulmonary lesions indicative of irreversible pulmonary hypertension. Neither the acute nor the subacute patient had chronic pulmonary vascular changes. All 3 patients had dilated right ventricular cavities and non-dilated left ventricular cavities and only the patient with chronic cor pulmonale had right ventricular hypertrophy.


Subject(s)
Pulmonary Heart Disease/diagnosis , Acute Disease , Adult , Aged , Chronic Disease , Female , Humans , Male , Middle Aged , Pulmonary Heart Disease/complications , Pulmonary Heart Disease/therapy
13.
Article in English, German | MEDLINE | ID: mdl-25799435

ABSTRACT

Cor pulmonale is considered an uncommon complication in horses with recurrent airway obstruction (RAO). This case report describes the history, clinical and further examination findings, treatment, progression and outcome of a horse diagnosed with cor pulmonale and paroxysmal atrial fibrillation of 2 days duration due to a severe exacerbation of RAO. To our best knowledge, this is the first report of RAO induced pulmonary hypertension in a horse causing atrial fibrillation. However, even severe cardiac changes due to respiratory dysfunction seem to be largely reversible in horses.


Subject(s)
Airway Obstruction/veterinary , Atrial Fibrillation/veterinary , Horse Diseases/therapy , Pulmonary Heart Disease/veterinary , Airway Obstruction/therapy , Animals , Atrial Fibrillation/therapy , Cardiac Catheterization , Horses , Hypertension, Pulmonary/veterinary , Pulmonary Heart Disease/therapy
14.
World J Gastroenterol ; 20(31): 10651-7, 2014 Aug 21.
Article in English | MEDLINE | ID: mdl-25152569

ABSTRACT

End stage liver disease (ESLD) is associated with many specific derangements in cardiovascular physiology, which influence perioperative outcomes and may profoundly influence diagnostic and management strategies in the preoperative period. This review focuses on evidence-based diagnosis and management of coronary, hemodynamic and pulmonary vascular disease in this population with an emphasis on specific strategies that may provide a bridge to transplantation. Specifically, we address the underlying prevalence of cardiovascular disease states in the ESLD population, and relevant diagnostic criteria thereof. We highlight traditional and non-traditional predictors of cardiovascular outcomes following liver transplant, as well as data to guide risk-factor based diagnostic strategies. We go on to discuss the alterations in cardiovascular physiology which influence positive- and negative-predictive values of standard noninvasive testing modalities in the ESLD population, and review the data regarding the safety and efficacy of invasive testing in the face of ESLD and its co-morbidities. Finally, based upon the totality of available data, we outline an evidence-based approach for the management of ischemia, heart failure and pulmonary vascular disease in this population. It is our hope that such evidence-driven strategies can be employed to more safely bridge appropriate candidates to liver transplant, and to improve their cardiovascular health and outcomes in the peri-operative period.


Subject(s)
End Stage Liver Disease/surgery , Heart Diseases/therapy , Liver Transplantation , Cardiomyopathies/therapy , Comorbidity , Coronary Artery Disease/therapy , End Stage Liver Disease/diagnosis , End Stage Liver Disease/epidemiology , Heart Diseases/diagnosis , Heart Diseases/epidemiology , Heart Diseases/physiopathology , Heart Failure/therapy , Hemodynamics , Humans , Predictive Value of Tests , Prevalence , Pulmonary Heart Disease/therapy , Risk Factors , Treatment Outcome , Waiting Lists
15.
Rofo ; 186(8): 751-61, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24756429

ABSTRACT

Chronic thromboembolic pulmonary hypertension (CTEPH) can be defined as pulmonary hypertension (resting mean pulmonary arterial pressure of 25 mm Hg or more determined at right heart catheterization) with persistent pulmonary perfusion defects. It is a rare, but underdiagnosed disease with estimated incidences ranging from 0.5% to 3.8% of patients after an acute pulmonary embolism (PE), and in up to 10% of those with a history of recurrent PE. CTEPH is the only form of pulmonary hypertension that can be surgically treated leading to normalization of pulmonary hemodynamics and exercise capacity in the vast majority of patients. The challenges for imaging in patients with suspected CTEPH are fourfold: the imaging modality should have a high diagnostic accuracy with regard to the presence of CTEPH and allow for differential diagnosis. It should enable detection of patients suitable for PEA with great certainty, and allow for quantification of PH by measuring pulmonary hemodynamics (mPAP and PVR), and finally, it can be used for therapy monitoring. This overview tries to elucidate the potential role of ECG-gated multidetector CT pulmonary angiography (MD-CTPA) and MR imaging, and summarizes the most important results that have been achieved so far. Generally speaking, ECG-gated MD-CTPA is superior to MR in the assessment of parenchymal and vascular pathologies of the lung, and allows for the assessment of cardiac structures. The implementation of iodine maps as a surrogate for lung perfusion enables functional assessment of lung perfusion by CT. MR imaging is the reference standard for the assessment of right heart function and lung perfusion, the latter delineating typical wedge-shaped perfusion defects in patients with CTEPH. New developments show that with MR techniques, an estimation of hemodynamic parameters like mean pulmonary arterial pressure and pulmonary vascular resistance will be possible. CT and MR imaging should be considered as complementary investigations providing comprehensive information in patients with CTEPH.


Subject(s)
Hypertension, Pulmonary/diagnosis , Magnetic Resonance Imaging/methods , Multidetector Computed Tomography/methods , Pulmonary Embolism/diagnosis , Angiography, Digital Subtraction/methods , Chronic Disease , Diagnosis, Differential , Hemodynamics/physiology , Humans , Hypertension, Pulmonary/physiopathology , Hypertension, Pulmonary/therapy , Image Enhancement/methods , Image Interpretation, Computer-Assisted/methods , Lung/blood supply , Lung/pathology , Magnetic Resonance Angiography/methods , Magnetic Resonance Imaging, Cine/methods , Pulmonary Artery/pathology , Pulmonary Embolism/physiopathology , Pulmonary Embolism/therapy , Pulmonary Heart Disease/diagnosis , Pulmonary Heart Disease/physiopathology , Pulmonary Heart Disease/therapy , Pulmonary Wedge Pressure/physiology , Sensitivity and Specificity , Ventricular Remodeling/physiology
16.
Crit Care Nurs Q ; 37(2): 188-98, 2014.
Article in English | MEDLINE | ID: mdl-24595256

ABSTRACT

Many people throughout the world are living with a severe pulmonary disease, known as pulmonary arterial hypertension. This disease has various etiologies and is often not diagnosed appropriately or early in the disease process, leading to limited, long-term survival. Fortunately in the past 20 years, medications and other options have been developed that provide patients with life-prolonging treatments that also increase their quality of life. Pathophysiology, disease identification and classification, and treatment options, focusing on current pharmacological treatments, are discussed in this article.


Subject(s)
Antihypertensive Agents/administration & dosage , Drug Approval , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/therapy , Administration, Inhalation , Administration, Oral , Antihypertensive Agents/pharmacology , Combined Modality Therapy , Epoprostenol/administration & dosage , Epoprostenol/analogs & derivatives , Female , Humans , Hypertension, Pulmonary/epidemiology , Infusions, Intravenous , Injections, Subcutaneous , Male , Piperazines/administration & dosage , Prognosis , Pulmonary Heart Disease/diagnosis , Pulmonary Heart Disease/epidemiology , Pulmonary Heart Disease/therapy , Purines/administration & dosage , Severity of Illness Index , Sildenafil Citrate , Sulfonamides/administration & dosage , Survival Rate , Treatment Outcome , United States , United States Food and Drug Administration
17.
Herz ; 39(1): 58-65, 2014 Feb.
Article in German | MEDLINE | ID: mdl-24638159

ABSTRACT

Pulmonary hypertension (PH) is a common phenomenon which may occur as a consequence of various diseases (e.g. heart failure, chronic lung diseases and pulmonary embolism), as a distinct disease of the small pulmonary arterioles or a combination of both. Independent from the origin, PH has an important impact on patient symptoms and prognosis. Establishment of an exact diagnosis and classification as well as an understanding of the hemodynamic interrelationships provide the basis for often challenging treatment decisions. Recently, the fifth World Symposium on PH took place in Nice, France, where important standards and definitions were specified. The most relevant results including the rating of novel treatment options are summarized in this article.


Subject(s)
Hypertension, Pulmonary/diagnosis , Pulmonary Heart Disease/diagnosis , Pulmonary Heart Disease/therapy , Pulmonary Medicine/standards , Humans , Hypertension, Pulmonary/complications , Hypertension, Pulmonary/etiology , Internationality , Practice Guidelines as Topic , Pulmonary Heart Disease/etiology , Treatment Outcome
18.
Dtsch Med Wochenschr ; 138(22): 1159-62, 2013 May.
Article in German | MEDLINE | ID: mdl-23700302

ABSTRACT

HISTORY: A 32-year-old woman was admitted to the emergency department because of acute dyspnea and syncope. A few minutes before the onset of symptoms, she had self-administered an intravenous injection of one gram of heroin combined with grinded flunitrazepam tablets. INVESTIGATIONS: Signs of acute cor pulmonale were detected on transthoracic echocardiography despite lack of pulmonary embolism in computed tomography. It was assumed that microembolisms were the cause of acute pulmonary hypertension after intravenous injection of heroin and flunitrazepam. TREATMENT AND COURSE: Because of lack of thrombus in CT scan therapeutic anticoagulation with unfractionated heparin and oxygen insufflation was initiated resulting in rapid improvement of oxygen saturation and blood pressure. On the following day pulmonary pressure in transthoracic echocardiography was already decreased significantly. Without signs of deep venous thrombosis in duplex scan and only a marginal sub segmental perfusion deficit in ventilation-perfusion-scintigraphy therapeutic anticoagulation was recommended for three months. CONCLUSION: The most likely cause of micro embolisms in this case are particles of talc, which are often used to cut heroin, or the microcrystalline cellulose used in tablets. There have been reports of tissue necrosis due to arterial embolism/vasospasm by crystalloid or oily substances (embolia cutis medicamentosa) in the extremities after intraarterial injection of grinded flunitrazepam tablets. Therefore it seems plausible that intravenous application may cause a serve but transient deficit of perfusion in pulmonary circulation.


Subject(s)
Flunitrazepam/toxicity , Heroin/poisoning , Pulmonary Heart Disease/chemically induced , Substance Abuse, Intravenous/complications , Substance Abuse, Intravenous/diagnosis , Ventricular Dysfunction, Right/chemically induced , Adult , Diagnosis, Differential , Female , Flunitrazepam/administration & dosage , Heroin/administration & dosage , Humans , Pulmonary Heart Disease/diagnosis , Pulmonary Heart Disease/therapy , Ventricular Dysfunction, Right/diagnosis , Ventricular Dysfunction, Right/therapy
19.
Curr Cardiol Rev ; 9(2): 157-73, 2013 May.
Article in English | MEDLINE | ID: mdl-23597299

ABSTRACT

The heart failure syndrome has been recognized as a significant contributor to cardiovascular disease burden in sub-Saharan African for many decades. Seminal knowledge regarding heart failure in the region came from case reports and case series of the early 20th century which identified infectious, nutritional and idiopathic causes as the most common. With increasing urbanization, changes in lifestyle habits, and ageing of the population, the spectrum of causes of HF has also expanded resulting in a significant burden of both communicable and non-communicable etiologies. Heart failure in sub-Saharan Africa is notable for the range of etiologies that concurrently exist as well as the healthcare environment marked by limited resources, weak national healthcare systems and a paucity of national level data on disease trends. With the recent publication of the first and largest multinational prospective registry of acute heart failure in sub-Saharan Africa, it is timely to review the state of knowledge to date and describe the myriad forms of heart failure in the region. This review discusses several forms of heart failure that are common in sub-Saharan Africa (e.g., rheumatic heart disease, hypertensive heart disease, pericardial disease, various dilated cardiomyopathies, HIV cardiomyopathy, hypertrophic cardiomyopathy, endomyocardial fibrosis, ischemic heart disease, cor pulmonale) and presents each form with regard to epidemiology, natural history, clinical characteristics, diagnostic considerations and therapies. Areas and approaches to fill the remaining gaps in knowledge are also offered herein highlighting the need for research that is driven by regional disease burden and needs.


Subject(s)
Cardiomyopathies/diagnosis , Cardiomyopathies/epidemiology , Heart Failure/diagnosis , Heart Failure/epidemiology , Africa South of the Sahara/epidemiology , Cardiomyopathies/therapy , Causality , Comorbidity , Endomyocardial Fibrosis/diagnosis , Endomyocardial Fibrosis/epidemiology , Endomyocardial Fibrosis/therapy , HIV Infections/epidemiology , Heart Failure/classification , Heart Failure/therapy , Humans , Hypertension/diagnosis , Hypertension/epidemiology , Hypertension/therapy , Myocardial Ischemia/diagnosis , Myocardial Ischemia/epidemiology , Myocardial Ischemia/therapy , Pulmonary Heart Disease/diagnosis , Pulmonary Heart Disease/epidemiology , Pulmonary Heart Disease/therapy , Rheumatic Heart Disease/diagnosis , Rheumatic Heart Disease/epidemiology , Rheumatic Heart Disease/therapy
20.
Cardiovasc Intervent Radiol ; 36(5): 1213-20, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23377237

ABSTRACT

Ethanol is an effective ablative agent used for the treatment of certain solid organ tumors and vascular malformations (VMs). The egress of ethanol beyond the target tissue can be associated with significant changes to the cardiopulmonary system that can lead to cardiac arrest. This article reviews the contemporary role of ethanol in tumor and VM treatment and discusses the physiological mechanisms of acute pulmonary hypertension and cardiovascular collapse. The importance of periprocedural recognition of the hemodynamic changes that can occur with the use of ethanol and the treatment of this condition are discussed.


Subject(s)
Ablation Techniques/methods , Ethanol/therapeutic use , Heart Failure/complications , Perioperative Care/methods , Pulmonary Heart Disease/complications , Solvents/therapeutic use , Ablation Techniques/adverse effects , Acute Disease , Anesthesia, General/methods , Animals , Dogs , Echocardiography, Transesophageal/methods , Ethanol/adverse effects , Heart Failure/diagnosis , Heart Failure/therapy , Humans , Pulmonary Heart Disease/diagnosis , Pulmonary Heart Disease/therapy , Solvents/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...